UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000014023
Receipt No. R000016335
Official scientific title of the study Evaluation of Placental Transfer of hydroxyethyl starch 130/0.42
Date of disclosure of the study information 2014/05/22
Last modified on 2017/05/23 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Evaluation of Placental Transfer of hydroxyethyl starch 130/0.42
Title of the study (Brief title) PT-HES study
Region
Japan

Condition
Condition Cesarean section
Classification by specialty
Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Rapid infusion of hydroxyethyl starch (HES) has confirmed the effectiveness of preventing spinal anesthesia induced hypotension during cesarean delivery. Because molecular size of HES is over 1,000 Dalton, HES seems not to transfer from mother to fetus throughout placenta. However, the placental transfer of HES has not corroborated.
The purpose of this study is to elucidate the placental transfer of HES from mother to fetus during cesarean section.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Weight distribution of HES in umbilical blood
Key secondary outcomes Weight distribution of HES in maternal bllod

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 HES 130/0.42
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria Patients who are planned cesarean section
Key exclusion criteria Preeclampsia
Target sample size 6

Research contact person
Name of lead principal investigator Katsuo TERUI
Organization Saitama medical center
Division name Division of obstetric anesthesia
Address 1981 Kamoda Kawagoe Saitama
TEL 049-228-3400
Email terui@saitama-med.ac.jp

Public contact
Name of contact person Yusuke MAZDA
Organization Saitama medical center
Division name Division of obstetric anesthesia
Address 1981 Kamoda Kawagoe Saitama
TEL 049-228-3400
Homepage URL
Email mazda@saitama-med.ac.jp

Sponsor
Institute Saitama medical university
Institute
Department

Funding Source
Organization Saitama medical university
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 埼玉医科大学総合医療センター産科麻酔科

Other administrative information
Date of disclosure of the study information
2014 Year 05 Month 22 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2014 Year 05 Month 07 Day
Anticipated trial start date
2015 Year 08 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 05 Month 21 Day
Last modified on
2017 Year 05 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016335